title: Analysis of the genotype and virulence of Staphylococcus epidermidis isolates from patients with infective endocarditis.
abstract: Staphylococcus epidermidis is one of the most common causes of infections of prosthetic heart valves (prosthetic valve endocarditis [PVE]) and an increasingly common cause of infections of native heart valves (native valve endocarditis [NVE]). While S. epidermidis typically causes indolent infections of prosthetic devices, including prosthetic valves and intravascular catheters, S. epidermidis NVE is a virulent infection associated with valve destruction and high mortality. In order to see if the differences in the course of infection were due to characteristics of the infecting organisms, we examined 31 S. epidermidis NVE and 65 PVE isolates, as well as 21 isolates from blood cultures (representing bloodstream infections [BSI]) and 28 isolates from nasal specimens or cultures considered to indicate skin carriage. Multilocus sequence typing showed both NVE and PVE isolates to have more unique sequence types (types not shared by the other groups; 74 and 71%, respectively) than either BSI isolates (10%) or skin isolates (42%). Thirty NVE, 16 PVE, and a total of 9 of the nasal, skin, and BSI isolates were tested for virulence in Caenorhabditis elegans. Twenty-one (70%) of the 30 NVE isolates killed at least 50% of the worms by day 5, compared to 1 (6%) of 16 PVE isolates and 1 (11%) of 9 nasal, skin, or BSI isolates. In addition, the C. elegans survival rate as assessed by log rank analyses of Kaplan-Meier survival curves was significantly lower for NVE isolates than for each other group of isolates (P < 0.0001). There was no correlation between the production of poly-beta(1-6)-N-acetylglucosamine exopolysaccharide and virulence in worms. This study is the first analysis suggesting that S. epidermidis isolates from patients with NVE constitute a more virulent subset within this species.
authors.affiliation: Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA.
authors.forename: Alastair B
authors.initials: AB
authors.lastname: Monk
authors.forename: Sam
authors.initials: S
authors.lastname: Boundy
authors.forename: Vivian H
authors.initials: VH
authors.lastname: Chu
authors.forename: Jill C
authors.initials: JC
authors.lastname: Bettinger
authors.forename: Jaime R
authors.initials: JR
authors.lastname: Robles
authors.forename: Vance G
authors.initials: VG
authors.lastname: Fowler
authors.forename: Gordon L
authors.initials: GL
authors.lastname: Archer
mesh_terms: D000818:Animals; D018441:Biofilms; D017173:Caenorhabditis elegans; D004697:Endocarditis, Bacterial / Q000382:microbiology*; D005798:Genes, Bacterial; D005838:Genotype; D006801:Humans; D016133:Polymerase Chain Reaction; D013203:Staphylococcal Infections / Q000382:microbiology*; D013212:Staphylococcus epidermidis / Q000276:immunology / Q000472:pathogenicity* / Q000502:physiology*
references.citation: J Clin Microbiol. 2008 May;46(5):1780-4
references.pmid: 18367572
references.citation: J Clin Microbiol. 1985 Dec;22(6):996-1006
references.pmid: 3905855
references.citation: Int J Food Microbiol. 1997 Apr 15;35(3):213-21
references.pmid: 9105930
references.citation: Antimicrob Agents Chemother. 2003 Nov;47(11):3574-9
references.pmid: 14576120
references.citation: J Clin Microbiol. 1987 Oct;25(10):2028-9
references.pmid: 3117846
references.citation: J Infect Dis. 1984 Nov;150(5):721-7
references.pmid: 6491379
references.citation: Infect Immun. 2003 Apr;71(4):2208-17
references.pmid: 12654843
references.citation: Am J Med. 1987 Oct;83(4):619-25
references.pmid: 3674050
references.citation: Ann Intern Med. 1983 Apr;98(4):447-55
references.pmid: 6838067
references.citation: Stat Med. 1987 Sep;6(6):679-87
references.pmid: 3479818
references.citation: Am J Med. 1994 Mar;96(3):200-9
references.pmid: 8154507
references.citation: Trends Microbiol. 2005 Mar;13(3):119-27
references.pmid: 15737730
references.citation: Cell. 1999 Jan 8;96(1):47-56
references.pmid: 9989496
references.citation: Proc Natl Acad Sci U S A. 2007 May 29;104(22):9469-74
references.pmid: 17517597
references.citation: Pediatr Res. 1995 Jan;37(1):70-4
references.pmid: 7700736
references.citation: Lancet Infect Dis. 2002 Nov;2(11):677-85
references.pmid: 12409048
references.citation: Infect Immun. 2002 Aug;70(8):4433-40
references.pmid: 12117954
references.citation: Diagn Microbiol Infect Dis. 2000 Feb;36(2):75-80
references.pmid: 10705046
references.citation: Infect Immun. 1999 Oct;67(10):5427-33
references.pmid: 10496925
references.citation: Lifetime Data Anal. 2006 Jun;12(2):191-203
references.pmid: 16817004
references.citation: J Clin Microbiol. 1987 Aug;25(8):1370-2
references.pmid: 3624436
references.citation: Microbiol Immunol. 2007;51(4):381-90
references.pmid: 17446677
references.citation: PLoS Pathog. 2007 Apr;3(4):e57
references.pmid: 17447841
references.citation: Eur J Clin Microbiol Infect Dis. 2006 Jun;25(6):365-8
references.pmid: 16767483
references.citation: J Clin Microbiol. 2007 Feb;45(2):616-9
references.pmid: 17151213
references.citation: Microbiology (Reading). 1997 Nov;143 ( Pt 11):3491-3500
references.pmid: 9387227
references.citation: J Clin Pathol. 1994 Aug;47(8):743-8
references.pmid: 7962630
references.citation: J Clin Microbiol. 1989 Mar;27(3):507-11
references.pmid: 2715323
references.citation: J Clin Microbiol. 2004 Dec;42(12):5614-9
references.pmid: 15583290
references.citation: Lett Appl Microbiol. 1991 Aug;13(2):90-2
references.pmid: 1367543
references.citation: Proc Natl Acad Sci U S A. 2002 May 28;99(11):7687-92
references.pmid: 12032344
references.citation: J Bacteriol. 2007 Mar;189(6):2540-52
references.pmid: 17220222
references.citation: Mol Microbiol. 2007 Jan;63(2):497-506
references.pmid: 17176256
references.citation: Clin Infect Dis. 2008 Jan 15;46(2):232-42
references.pmid: 18171255